| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 1, 2026 | The Role of Ethical Oversight and Algorithmic Bias in Automated Pharmacovigilance | Vikalp Khare, Director, Head of US GPV Safety Data Management at Otsuka
Pharmacovigilance is changing quietly but fundamentally. You can feel it in the way adverse event reports move faster through systems, in how signals surface earlier, a... |
| Nov 12, 2025 | Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti® and Rexulti® driven by additional investments | VALBY, Denmark, Nov. 12, 2025 /PRNewswire/ -- Key highlights
Lundbeck's total revenue grew by +14% CER[1] (+13% DKK) to DKK 18,537 million in the first nine months of 2025. Growth in the U.S. and Europe was the driver of this strong perform... |
| Nov 11, 2025 | Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti[®] and Rexulti[®] driven by additional investments | Lundbeck delivers 14% CER revenue growth, reflecting stronger momentum from Vyepti[®] and Rexulti[®] driven by additional investments
Tue, Nov 11, 2025 15:34 CET Report this content
Key highlights
Lundbeck’s total revenue grew by +14% CER[1... |
| Nov 5, 2025 | A New Era of Leadership: CLOC Unveils Expanded, Modernized Board to Unite the Legal Ecosystem | New board brings together seasoned legal operations executives, in-house counsel, and technology innovators to drive industry-wide transformation.
SAN JOSE, Calif., Nov. 5, 2025 /PRNewswire-PRWeb/ -- CLOC (Corporate Legal Operations Consort... |
| Sep 20, 2025 | Otsuka and Lundbeck receive Complete Response Letter from U.S. FDA for sNDA of REXULTI® (brexpiprazole) in combination with sertraline for the treatment of adults with PTSD | Otsuka and Lundbeck receive Complete Response Letter from U.S. FDA for sNDA of REXULTI® (brexpiprazole) in combination with sertraline for the treatment of adults with PTSD
Sat, Sep 20, 2025 08:00 CET Report this content
Valby, Denmark, 20 ... |
| Jul 18, 2025 | Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting for the Treatment of Post-Traumatic Stress Disorder (PTSD) | Otsuka and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting for the Treatment of Post-Traumatic Stress Disorder (PTSD)
Fri, Jul 18, 2025 23:24 CET Report this content
Valby, Denmark, 18 July 202... |
| Jul 15, 2025 | Advancing Psychedelic Compounds: From Preclinical Discovery to Translational Insight, Upcoming Webinar Hosted by Xtalks | www.transpharmation.com
In this free webinar, learn how drug discrimination remains an essential tool in psychedelic research and new chemical entity (NCE) discovery. It has been used to help translate dose exposures and time course of NCEs... |
| May 22, 2024 | Click Therapeutics acquires Better Therapeutics assets | figcaption>span]:font-sans">
Click Therapeutics, a provider of prescription treatments via a smartphone, has acquired assets of Better Therapeutics.
Why it matters: Several companies have made early headway in the space only to s... |
| May 8, 2024 | EXECUTIVE PRODUCER BRADLEY COOPER IN PRODUCTION FOR CAREGIVING, THE NEW DOCUMENTARY ON THE STATE AND STAKES OF PROVIDING CARE IN AMERICA | PROJECT SLATED FOR SPRING 2025 PREMIERE ON PBS
Nationwide Well Beings Campaign from WETA Leverages Power of Public Media, Engagement Partners, and Extended Digital Series to Highlight Caregiving Challenges and Advances
"There are only ... |
| May 6, 2024 | Otsuka Precision Health Launches: Personalized Care Powered by AI and Digital Solutions | What You Should Know:
– Otsuka America, Inc. (OAI) today announced the formation of Otsuka Precision Health (OPH), a new subsidiary dedicated to transforming patient care through innovative digital solutions and a data-driven approach.
– OP... |
| Jun 26, 2023 | Prescription Digital Therapeutics Are Expanding What It Means To Treat Mental Health | More mental health treatment options are needed as demand continues to rise. |
| Mar 29, 2023 | 9 psychedelics startups that are winning over top venture investors | A handful of psychedelics companies have received interest from mainstream investors. jackfoto/iStock/Getty Images Plus This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
The psychedelics in... |
| Nov 9, 2022 | Compass Pathways' new CEO says data from his firm's upcoming clinical trial could finally persuade Big Pharma to jump into the psychedelics industry | Kabir Nath, the CEO of Compass Pathways. Compass Pathways This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Redeem now
Compass Pathways is set to start its biggest clinical trial yet by the... |
| Jul 23, 2021 | Happify Health’s first-ever Rx mental health app should worry its peers | The news: Digital therapeutics (DTx) vendor Happify Health unveiled the first prescription digital therapy to treat patients with both major depressive disorder (MDD) and generalized anxiety disorder, a web and mobile app dubbed Ensemble. T... |
| Jul 21, 2021 | See the pitch deck that Compass Pathways used to raise $80 million and fuel its rise into one of the world's biggest psychedelics companies | Psilocybin mushrooms on a mossy log jackfoto/iStock/Getty Images Plus This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Compass Pathways is one of the biggest psychedelics companies in the ... |
| Jul 8, 2021 | Otsuka Signs Three-Year Collaboration with Holmusk to Enhance Digital Health and Data Analytics for Global Behavioral Health Programs | PRINCETON, N.J., July 8, 2021 /PRNewswire/ -- Otsuka Pharmaceutical Development & Commercialization, Inc. ("Otsuka"), announces today that it has entered a three-year collaboration with Holmusk Inc. ("Holmusk"), a gl... |
| Feb 28, 2021 | Otsuka launches pivotal trial of digital therapeutics for depression | They plan to enroll up to 540 patients in a randomized, controlled trial that will test the digital therapeutic’s efficacy in patients that are taking antidepressants. The remote trial will be conducted using Verily’s Project Baseline platf... |
| Feb 9, 2021 | When antidepressants aren’t enough, add-on therapies may make a difference for those with depression | (BPT) - This article is sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck.
In the United States, an estimated 17.3 million American adults suffer from major depressive disorder (MDD), or depression. Depression is a serious menta... |
| Feb 9, 2021 | When antidepressants aren’t enough, add-on therapies may make a difference for those with depression | (BPT) - This article is sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck.
In the United States, an estimated 17.3 million American adults suffer from major depressive disorder (MDD), or depression. Depression is a serious menta... |
| Dec 22, 2020 | M&A in healthcare: some of the biggest deals of 2020 | Teladoc bought Livongo for $18.5B; Blackstone acquired Ancestry for $4.7B; GRAIL was bought for $8B
Despite all the turmoil that COVID, and the resulting pandemic, caused in the healthcare system over the last year, that has not stopped inv... |
| Oct 12, 2018 | Otsuka, Proteus expand agreement around digital medicines | As part of the expanded agreement, Otsuka also made an $88 million investment in Proteus, in the form of equity and other payments, to help further development of digital medicines.
While Proteus CEO said in an interview shortly after the F... |
| Oct 11, 2018 | Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advance Digital Medicines for Mental Health | PRINCETON, N.J. & REDWOOD CITY, Calif.–(BUSINESS WIRE)–October 11, 2018–
Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announce the signing of an expanded global collaboration agreement that will st... |
| Aug 30, 2018 | At $1,650 per month, the first digital pill will soon roll out to certain Medicaid patients with mental illness | The first digital pill will carry a price tag of $1,650 per month and soon be rolled out commercially to the first patients: people with mental illness covered by Medicaid, likely in regions including Florida and Virginia.
The pill, sold by... |
| May 28, 2018 | ‘Under-the-radar’ companies could become hot acquisition targets in 2018 | But in addition to such high-profile deals, a number of “under-the-radar” companies could also be potential acquisition targets this year. That’s one of the conclusions of a report from Informa forecasting life-sciences M&A in 2018.
Inf... |
| 2018 | What Happened in Plant-Based Protein in 2017? | The plant-based protein startups using technology to create and mass produce their products have traditionally received support from a small, but dedicated group of investors, which is increasingly being joined by major food and agriculture... |
| Jul 28, 2017 | Ag Industry Brief: AGCO Acquires Precision Planting, CropLogic Going Public, Plant-Based M&A, more | CropLogic to List on ASX After Acquiring Professional Ag Services
New Zealand in-field IoT provider CropLogic is set to go public on the Australian Stock Exchange. The company plans to raise $8 million in exchange for approximately 30% of i... |
| Mar 5, 2017 | OPC to Acquire NVF-backed Neurovance | TOKYO–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. announces an agreement with Neurovance, Inc. under which OPC has agreed to acquire Neurovance, a privately held, venture-funded, clinical stage pharmaceutical company focused on attentio... |
| Mar 5, 2017 | OPC to Acquire NVF-backed Neurovance | TOKYO–(BUSINESS WIRE)–Otsuka Pharmaceutical Co., Ltd. announces an agreement with Neurovance, Inc. under which OPC has agreed to acquire Neurovance, a privately held, venture-funded, clinical stage pharmaceutical company focused on attentio... |
| Dec 22, 2015 | CB Insights identifies 5 applications for Internet of Things in healthcare from the sublime to OTT | Computer Vision is a pretty broad area but basically it is nursing technology such as artificial intelligence to amplify vision. Although CB Insights uses drones as an example, there are some applications I and some of my colleagues have co... |
| Dec 1, 2015 | These pharma and digital health collaborations are poised to transform clinical trials | This post has been updated from an earlier version
Propeller Health added a second big pharma partner with its GlaxoSmithKline research and development deal to produce sensors for the company’s Ellipta dry powder inhaler, according to a com... |
| Mar 19, 2014 | Healthcare startups got 40% of the $1B invested in Internet of Things ideas last year | Orthosensor is a medical device that transmits information to orpthopedic surgeons in real time to let them know whether knee replacements are implanted the right way to reduce the need for additional surgery. It also is intended to extend ... |
| Oct 1, 2012 | With eyes toward IND-enabling studies, TB drug startup searches for a Big Pharma partner | With that in mind, a humble Indiana startup is hoping to deliver a stable, oral drug that’s dosed once a day or less to help prevent patients from developing those drug-resistant forms.
Aarden Pharmaceuticals’ therapeutic, designed to be us... |
| Nov 25, 2008 | GangaGen cultures $5.4M to treat bacterial infections | Biotech firm GangaGen, based in Palo Alto, Calif., brought in $5.4 million in fifth-round funding from ATEL Ventures, Otsuka Pharmaceuticals and ICF Ltd. to develop treatments for bacterial infections. The company specializes in antibiotic-... |
| Otsuka launches pivotal trial of digital therapeutics for depression | Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms.
It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is... |
| Happify Health’s first-ever Rx mental health app should worry its peers | The news: Digital therapeutics (DTx) vendor Happify Health unveiled the first prescription digital therapy to treat patients with both major depressive disorder (MDD) and generalized anxiety disorder, a web and mobile app dubbed Ensemble. T... |
| Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully Remote Clinical Trial Using Digital Therapeutics as Adjunctive Therapy in Adults With Major Depressive Disorder | PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Feb 24, 2021--
Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) and Click Therapeutics, Inc. announce the initiation of the Mirai study, a landmark fully remote clinic... |
| CB Insights identifies 5 applications for Internet of Things in healthcare from the sublime to OTT | The number of connected devices is truly startling. Gartner estimates that there are currently about 4.9 billion connected devices and expects that to grow 30 percent to 6.39 billion next year. A CB Insights article goes beyond the garden v... |
| Addressing the mental health pandemic requires a patient-centric approach | The mental well-being of individuals across the globe has been challenged in unimaginable ways due to Covid-19.
A Centers for Disease Control and Prevention (CDC) Household Pulse survey conducted between April 2020 and February 2021 found a... |
| Driving diversity and democratization within clinical trials | For decades, clinical trial recruitment was a one-way, transactional process. The quickest route to getting innovative drugs to market was through a flawed system that emphasized gathering a quality data set over the simultaneous need to en... |
| These pharma and digital health collaborations are poised to transform clinical trials | This post has been updated from an earlier version
Propeller Health added a second big pharma partner with its GlaxoSmithKline research and development deal to produce sensors for the company’s Ellipta dry powder inhaler, according to a com... |
| Insider identified 13 drug companies that are in a dangerous financial position and struggling to survive through 2022 | Mark Foley, CEO of Revance Therapeutics, Cameron Durrant, CEO of Humanigen, Nick Leschly Former CEO of Bluebird Bio, and Henry Ji, CEO of Sorrento Therapeutics, Revance Therapeutics; Humanigen; Sorrento Therapeutics; Wendy Maeda/Getty Image... |
| Understanding a rare kidney condition: genetics, symptoms & progression | By Dr. Nelson Kopyt, Contributor
Dr. Kopyt is a paid consultant of Otsuka America Pharmaceutical, Inc.
Family history often reveals important health information for individuals. This history can be used as a roadmap for important health dec... |
| Otsuka, Proteus expand agreement around digital medicines | A collaboration between a Japanese drugmaker and a US company responsible for the first Food and Drug Administration-approved pill to include a digital sensor to track ingestion are expanding their partnership.
Redwood City, California-base... |
| America’s Mental Healthcare System in Dire Need of Transformation | By now it’s common knowledge that the often siloed, under-resourced American mental health system is bowing under the strain of the Covid-19 pandemic. Worse, the cracks that already existed in treating chronic mental illness before the glob... |
| With eyes toward IND-enabling studies, TB drug startup searches for a Big Pharma partner | It’s been more than four decades since a new drug for tuberculosis has been approved by the FDA. Although Janssen is igniting hope with bedaquiline, which has been given priority review by the FDA and is set to begin late-stage trials this ... |
| ‘Under-the-radar’ companies could become hot acquisition targets in 2018 | The year 2018 is less than halfway through and has already seen some high-profile merger and acquisition activity in biotechnology and pharmaceuticals.
Last month, there was Novartis’ $8.7 billion acquisition of AveXis, which is developing ... |
| Healthcare startups got 40% of the $1B invested in Internet of Things ideas last year | The Internet of Things was a hot area for investment last year. Of the 153 deals raising $1 billion from venture capitalists, a big fat slice — 61 — were healthcare IT companies and health and wellness businesses, according to CB Insights.
... |
